<VariationArchive VariationID="371737" VariationName="NM_000286.3(PEX12):c.730_733dup (p.Leu245fs)" VariationType="Duplication" Accession="VCV000371737" Version="22" RecordType="classified" NumberOfSubmissions="10" NumberOfSubmitters="9" DateLastUpdated="2024-06-17" DateCreated="2015-10-11" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="358425" VariationID="371737">
      <GeneList>
        <Gene Symbol="PEX12" FullName="peroxisomal biogenesis factor 12" GeneID="5193" HGNC_ID="HGNC:8854" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="35574795" stop="35578571" display_start="35574795" display_stop="35578571" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="33901813" stop="33905655" display_start="33901813" display_stop="33905655" Strand="-" />
          </Location>
          <OMIM>601758</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000286.3(PEX12):c.730_733dup (p.Leu245fs)</Name>
      <CanonicalSPDI>NC_000017.11:35576128:AGGCA:AGGCAGGCA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="35576128" stop="35576129" display_start="35576128" display_stop="35576129" variantLength="4" positionVCF="35576128" referenceAlleleVCF="A" alternateAlleleVCF="AAGGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="33903147" stop="33903148" display_start="33903147" display_stop="33903148" variantLength="4" positionVCF="33903147" referenceAlleleVCF="A" alternateAlleleVCF="AAGGC" />
      </Location>
      <ProteinChange>L245fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000286.2" sequenceAccession="NM_000286" sequenceVersion="2" change="c.730_733dup">
            <Expression>NM_000286.2:c.730_733dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.33903149_33903152dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.33903149_33903152dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.35576130_35576133dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.35576130_35576133dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008447.1" sequenceAccession="NG_008447" sequenceVersion="1" change="g.7506_7509dup">
            <Expression>NG_008447.1:g.7506_7509dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000286.3" sequenceAccession="NM_000286" sequenceVersion="3" change="c.730_733dup" MANESelect="true">
            <Expression>NM_000286.3:c.730_733dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000277.1" sequenceAccession="NP_000277" sequenceVersion="1" change="p.Leu245fs">
            <Expression>NP_000277.1:p.Leu245fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA8504850" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="601758.0001" DB="OMIM" />
        <XRef Type="rs" ID="61752107" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000286.3(PEX12):c.730_733dup (p.Leu245fs) AND Peroxisome biogenesis disorder type 3B" Accession="RCV000409475" Version="2">
        <ClassifiedConditionList TraitSetID="550">
          <ClassifiedCondition DB="MedGen" ID="C3550693">Peroxisome biogenesis disorder type 3B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-08-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000286.3(PEX12):c.730_733dup (p.Leu245fs) AND Peroxisome biogenesis disorder 3A (Zellweger)" Accession="RCV000410995" Version="15">
        <ClassifiedConditionList TraitSetID="8948">
          <ClassifiedCondition DB="MedGen" ID="C3553929">Peroxisome biogenesis disorder 3A (Zellweger)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-13" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000286.3(PEX12):c.730_733dup (p.Leu245fs) AND not provided" Accession="RCV000728570" Version="7">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-06-21" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000286.3(PEX12):c.730_733dup (p.Leu245fs) AND Peroxisome biogenesis disorder" Accession="RCV000781710" Version="1">
        <ClassifiedConditionList TraitSetID="7944">
          <ClassifiedCondition DB="MedGen" ID="C1832200">Peroxisome biogenesis disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-08-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000286.3(PEX12):c.730_733dup (p.Leu245fs) AND PEX12-related disorder" Accession="RCV003335311" Version="1">
        <ClassifiedConditionList TraitSetID="87315">
          <ClassifiedCondition>PEX12-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-13" NumberOfSubmissions="10" NumberOfSubmitters="9" DateCreated="2015-10-11" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14571262</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15542397</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19105186</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19877282</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21031596</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25287621</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26094004</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29389947</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9090384</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9792857</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PEX12</URL>
        </Citation>
        <DescriptionHistory Dated="2022-09-14">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-07-15">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-08-13">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="550" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4320" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder type 3B</ElementValue>
                <XRef ID="MONDO:0009959" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBD3B</ElementValue>
                <XRef Type="MIM" ID="266510" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term "ZSD" is now used to refer to all individuals with a defect in one of the ZSD-PEX genes regardless of phenotype. Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and the long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Individuals with intermediate/milder ZSD do not have congenital malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss), neurologic involvement (ataxia, polyneuropathy, and leukodystrophy), liver dysfunction, adrenal insufficiency, and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.</Attribute>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15226" />
                <XRef ID="15226" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301621</ID>
                <ID Source="BookShelf">NBK1448</ID>
              </Citation>
              <XRef ID="44" DB="Orphanet" />
              <XRef ID="772" DB="Orphanet" />
              <XRef ID="C3550693" DB="MedGen" />
              <XRef ID="MONDO:0009959" DB="MONDO" />
              <XRef Type="MIM" ID="266510" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7944" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5752" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder</ElementValue>
                <XRef ID="INHP_50" DB="Ege University Pediatric Genetics, Ege University" />
                <XRef ID="MONDO:0019234" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS214100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALD: Adrenoleukodystrophy, X-Linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PEROXISOME BIOGENESIS DISORDER (NEONATAL ADRENOLEUKODYSTROPHY/INFANTILE REFSUM DISEASE)</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INFANTILE PHYTANIC ACID STORAGE DISEASE</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PEROXISOME BIOGENESIS DISORDER (NALD/IRD)</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorders, Zellweger syndrome spectrum</ElementValue>
                <XRef ID="Peroxisome+biogenesis+disorders/5684" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBDS</ElementValue>
                <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PBD, ZSS</ElementValue>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term "ZSD" is now used to refer to all individuals with a defect in one of the ZSD-PEX genes regardless of phenotype. Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and the long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Individuals with intermediate/milder ZSD do not have congenital malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss), neurologic involvement (ataxia, polyneuropathy, and leukodystrophy), liver dysfunction, adrenal insufficiency, and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.</Attribute>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11890" />
                <XRef ID="11890" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000501626" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501625" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000070507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501629" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520399" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501647" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501466" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501474" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525961" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000004880" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592488" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000070509" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501632" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318975" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501472" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501630" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318886" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318883" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028503" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501628" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501631" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501644" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593050" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501635" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501633" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501473" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028499" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301621</ID>
                <ID Source="BookShelf">NBK1448</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated lysophosphatidylcholines, X-Linked Adrenoleukodystrophy (X-ALD), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, X-ALD: Elevated lysophosphatidylcholines C24:0, C26:0, 2023</CitationText>
              </Citation>
              <XRef ID="79189" DB="Orphanet" />
              <XRef ID="C1832200" DB="MedGen" />
              <XRef ID="MONDO:0019234" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS214100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="87315" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="68865" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PEX12-related disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PEX12-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">PEX12-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="8948" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17429" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 3A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0013927" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)</ElementValue>
                <XRef Type="Allelic variant" ID="601758.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0002" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 3A</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBD3A</ElementValue>
                <XRef ID="GTR000522760" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="614859" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The peroxisomal biogenesis disorder (PBD) Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).
For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.
Individuals with PBDs of complementation group 3 (CG3) have mutations in the PEX12 gene. For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614859" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15858" />
                <XRef ID="15858" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C3553929" DB="MedGen" />
              <XRef ID="MONDO:0013927" DB="MONDO" />
              <XRef Type="MIM" ID="614859" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="28419" SubmissionDate="2017-01-31" DateLastUpdated="2015-10-11" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601758.0001_PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)" title="PEX12, 4-BP INS, 733GCCT_PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)" />
        <ClinVarAccession Accession="SCV000028419" DateUpdated="2015-10-11" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In fibroblasts from a patient (PBD097) with peroxisome biogenesis disorder of complementation group 3 (PBD3A; 614859), Chang et al. (1997) identified compound heterozygosity for a 4-bp insertion after nucleotide 733 of the PEX12 gene and a single T insertion after nucleotide 744 (601758.0002). The 4-bp insertion creates a new Cac8I restriction site.</Attribute>
              <Citation>
                <ID Source="PubMed">9090384</ID>
              </Citation>
              <XRef DB="OMIM" ID="614859" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX12" />
          </GeneList>
          <Name>PEX12, 4-BP INS, 733GCCT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP INS, 733GCCT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601758.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1673152" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-16" DateCreated="2018-12-16">
        <ClinVarSubmissionID localKey="64168_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000856162" DateUpdated="2018-12-16" DateCreated="2018-12-16" Type="SCV" Version="1" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-04-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL ClinVar v180209 classification definitions</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/kvqgb2ud/egl_clinvar_v180209_classification_definitions.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX12" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="17" alternateAllele="AGGC" referenceAllele="-" start="33903148" stop="33903151" variantLength="4" />
            <GeneLocation>NM_000286.2:Ex3</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI972663" />
            <XRef DB="dbSNP" ID="61752107" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PEX12</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1789826" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="1365739" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000914758" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-09-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21031596</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19105186</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15542397</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9090384</ID>
          </Citation>
          <Comment>The PEX12 c.730_733dupGCCT (p.Leu245CysfsTer19) variant has been reported in two studies and identified in three patients in a compound heterozygous state and one patient in a heterozygous state, all with peroxisome biogenesis disorders, with three specifically noted to be in the Zellweger syndrome spectrum (Chang et al. 1997; Steinberg et al. 2004; Yik et al. 2009; Ebberink et al. 2011). All individuals with the variant in a compound heterozygous state had a second insertion variant. Control data are unavailable for the p.Leu245CysfsTer19 variant, but it is reported at a frequency of 0.000045 in the European (non-Finnish) population of the Exome Aggregation Consortium. To evaluate the effect of PEX12 expression on peroxisomal protein import, Chang et al. (1997) used patient fibroblasts and noted that when the variant was present, cDNA expression was observed in the cytoplasm only; however, expression of PEX12 in these cells reversed the effect and import into the peroxisomes was observed. Based on the evidence and due to the potential impact of frameshift variants, the p.Leu245CysfsTer19 variant is classified as pathogenic for Zellweger syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="17" alternateAllele="AAGGC" referenceAllele="A" start="33903147" stop="33903147" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000286.2:c.730_733dupGCCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614859" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1796594" SubmissionDate="2019-04-24" DateLastUpdated="2019-06-02" DateCreated="2019-06-02">
        <ClinVarSubmissionID localKey="NM_000286.2:c.730_733dupGCCT|MedGen:C1832200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000919973" DateUpdated="2019-06-02" DateCreated="2019-06-02" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19877282</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19105186</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9792857</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29389947</ID>
          </Citation>
          <Comment>Variant summary: PEX12 c.730_733dupGCCT (p.Leu245CysfsX19) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. A truncation downstream of this position have been classified as pathogenic by our laboratory, c.888_889delCT (p.Leu297fsX12). The variant allele was found at a frequency of 1.6e-05 in 244662 control chromosomes (gnomAD). The variant, c.730_733dupGCCT has been reported in the literature in individuals affected with Zellweger Syndrome spectrum disorders (Chang_1998, Cordoba_2018, Ebberink_2010,Yik_2009). These data indicate that the variant may be associated with disease. One publication reports experimental evidence evaluating an impact on protein function, however, does not allow convincing conclusions about the variant effect (Chang_1998). A ClinVar submission from another clinical diagnostic laboratory (evaluation after 2014) cites the variant as "pathogenic." Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000286.2:c.730_733dupGCCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Peroxisome biogenesis disorders, Zellweger syndrome spectrum</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1832200" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5494893</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="951351" SubmissionDate="2016-11-23" DateLastUpdated="2022-12-24" DateCreated="2017-01-06">
        <ClinVarSubmissionID localKey="593190|OMIM:266510" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000487601" DateUpdated="2022-12-24" DateCreated="2017-01-06" Type="SCV" Version="2" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-08-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9090384</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19105186</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rb7nm21v/ar_xl2015criteria.pdf</URL>
            <CitationText>mdi-5618_320494_Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015).pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000286.2:c.730_733dupGCCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="266510" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Counsyl2016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="951352" SubmissionDate="2016-11-23" DateLastUpdated="2022-12-24" DateCreated="2017-01-06">
        <ClinVarSubmissionID localKey="593190|OMIM:614859" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000487602" DateUpdated="2022-12-24" DateCreated="2017-01-06" Type="SCV" Version="2" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-08-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9090384</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19105186</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rb7nm21v/ar_xl2015criteria.pdf</URL>
            <CitationText>mdi-5618_320494_Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015).pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000286.2:c.730_733dupGCCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614859" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Counsyl2016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5027349" SubmissionDate="2023-07-19" DateLastUpdated="2023-07-22" DateCreated="2022-09-17">
        <ClinVarSubmissionID localKey="GDXSV:279978" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002571593" DateUpdated="2023-07-22" DateCreated="2022-09-17" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Not observed at a significant frequency in large population cohorts (gnomAD); Frameshift variant in the C-terminus predicted to result in protein truncation, as the last 115 amino acids are lost and replaced with 18 incorrect amino acids. Human Gene Mutation Database (HGMD); This variant is associated with the following publications: (PMID: 9090384, 19105186, 21031596, 19877282, 15542397, 9792857, 29389947)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX12" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:2721249</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000286.2:c.730_733dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_129_20220914054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_203_20230719054203</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7569951" SubmissionDate="2023-09-19" DateLastUpdated="2023-10-21" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="NM_000286.2:c.730_733dup|PEX12-related disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004046226" DateUpdated="2023-10-21" DateCreated="2023-10-21" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This frameshift variant is found in the last exon of PEX12 and it is therefore predicted to escape nonsense-mediated mRNA decay (NMD). Truncating variants located downstream of this alteration have been reported in individuals with PEX12-related disorders in the literature (PMID: 26094004). This variant, also referred to as c.733-734insGCCT and c.733-734insGCC (p.L245Cfsx19), has been previously reported as a compound heterozygous change in two individuals with peroxisome biogenesis disorder (PMID: 9090384, 9792857, 15542397, 29389947, 21031596). The c.730_733dup (p.Leu245CysfsTer19) variant is present in the heterozygous state in the gnomAD population database at a frequency of 0.0016% (4/249910) and is absent in the homozygous state, thus is presumed to be rare. Based on the available evidence, the c.730_733dup (p.Leu245CysfsTer19) variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000286.2:c.730_733dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PEX12-related disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13808474</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1844793" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4554212|MedGen:C3553929" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000950691" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9090384</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19105186</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9090384</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9792857</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14571262</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21031596</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25287621</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26094004</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu245Cysfs*19) in the PEX12 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 115 amino acid(s) of the PEX12 protein. This variant is present in population databases (rs61752107, gnomAD 0.004%). This premature translational stop signal has been observed in individuals with peroxisome biogenesis disorders (PMID: 9090384, 19105186). This variant is also known as c.733_734insGCCT. ClinVar contains an entry for this variant (Variation ID: 371737). Studies have shown that this premature translational stop signal alters PEX12 gene expression (PMID: 9090384). This variant disrupts a region of the PEX12 protein in which other variant(s) (p.Leu297Thrfs*12) have been determined to be pathogenic (PMID: 9792857, 14571262, 21031596, 25287621, 26094004). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.33903147_33903148insAGGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3553929" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7850253" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000286.3:c.730_733dup|OMIM:614859" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004201426" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000286.3:c.730_733dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614859" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1789826" TraitType="Disease" MappingType="XRef" MappingValue="614859" MappingRef="OMIM">
        <MedGen CUI="C3553929" Name="Peroxisome biogenesis disorder 3A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7850253" TraitType="Disease" MappingType="XRef" MappingValue="614859" MappingRef="OMIM">
        <MedGen CUI="C3553929" Name="Peroxisome biogenesis disorder 3A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1673152" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1796594" TraitType="Disease" MappingType="Name" MappingValue="Peroxisome biogenesis disorders, Zellweger syndrome spectrum" MappingRef="Preferred">
        <MedGen CUI="C1832200" Name="Peroxisome biogenesis disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1844793" TraitType="Disease" MappingType="XRef" MappingValue="C3553929" MappingRef="MedGen">
        <MedGen CUI="C3553929" Name="Peroxisome biogenesis disorder 3A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="951351" TraitType="Disease" MappingType="XRef" MappingValue="266510" MappingRef="OMIM">
        <MedGen CUI="C3550693" Name="Peroxisome biogenesis disorder type 3B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569951" TraitType="Disease" MappingType="Name" MappingValue="PEX12-related disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="PEX12-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="28419" TraitType="Disease" MappingType="Name" MappingValue="PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)" MappingRef="Preferred">
        <MedGen CUI="C3553929" Name="Peroxisome biogenesis disorder 3A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="951352" TraitType="Disease" MappingType="XRef" MappingValue="614859" MappingRef="OMIM">
        <MedGen CUI="C3553929" Name="Peroxisome biogenesis disorder 3A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5027349" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

